Lv01
0 积分 2024-09-09 加入
Psoriasis
4小时前
待确认
Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis
5小时前
已完结
Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety
5天前
已完结
Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation
5天前
已完结
Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients
9天前
已完结
Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities
9天前
已完结
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials
11天前
已完结
Psoriasis
3个月前
已完结
Biologics for Psoriasis
3个月前
已完结
皖公网安备34019202002308
